Welcome to our dedicated page for Kimberly-Clark SEC filings (Ticker: KMB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Kimberly-Clark Corporation’s SEC filings document its consumer products business, Nasdaq-listed common stock and formal reporting as an operating company. Material-event reports furnish quarterly and annual results, financial condition updates and exhibits, including Inline XBRL cover-page data and earnings releases.
Other filings cover proxy and governance disclosures, shareholder voting matters, executive officer departures and interim accounting-officer responsibilities, compensation arrangements, material agreements, registration-statement and proxy/prospectus materials, and capital-structure information. The record also identifies the company’s common stock with $1.25 par value and the exchange registration for KMB on Nasdaq.
Stacey J. Panayiotou, Chief Human Resources Officer of Kimberly-Clark Corp. (KMB), filed an initial Form 3 reporting the event dated 09/10/2025. The filing states no securities are beneficially owned by the reporting person as of that date. The form was signed by an attorney-in-fact on behalf of Ms. Panayiotou.
Kimberly-Clark (KMB) Form 4 filing reports that Chief Digital & Technology Officer Zackery A. Hicks sold 15,038 common shares on 08/04/2025. The weighted-average sale price was $133.40 per share, with individual trades executed between $133.38 and $133.48. Following the disposition, Hicks’ direct beneficial ownership decreased to 14,321 shares, down from 29,359, a reduction of roughly 51%. No derivative securities were acquired or disposed of, and no Rule 10b5-1 trading plan was indicated. The filing was submitted by attorney-in-fact Jeffrey S. McFall. Apart from this single sale, the document contains no additional transactions, earnings data or material corporate events.
Kimberly-Clark’s Q2-25 10-Q shows modest top-line softness, margin pressure and heavy restructuring, offset by progress on the strategic portfolio shift.
- Continuing-ops net sales slipped 1.6% YoY to $4.16 bn; six-month sales -4.0% to $8.22 bn. Organic growth was positive (+3.9% Q2) but more than offset by divestitures, business exits and FX.
- GAAP operating profit rose 9.8% YoY to $592 mn, helped by lapping prior-year restructuring charges. Adjusted operating profit fell 2.2% as lower pricing, input inflation and tariffs (≈$170 mn FY impact) outweighed $110 mn of productivity gains.
- Diluted EPS from continuing ops eased to $1.33 (-1.5%); total EPS $1.53 (-5%). FY-to-date EPS is $3.23 (-8%).
- 2024 Transformation Initiative logged $122 mn pre-tax in Q2 ($199 mn YTD); total expected cost ≈$1.5 bn with completion by 2026, targeting $3.0 bn gross productivity savings.
- IFP Business reclassified as discontinued ops; JV with Suzano will yield ~$1.7 bn cash for 51% stake (closing mid-2026). Q2 discontinued income was $68 mn (-24%).
- Cash from operations fell to $1.10 bn (-25% YoY) on working-capital build; cash balance $634 mn versus $1.01 bn YE-24. Net debt declined ~$177 mn YTD.
- Segment trends: North America sales -1.9%, OP -4.0%; International Personal Care sales +0.4%, OP -12.9% due to FX and inflation.
- Balance sheet remains solid: equity up to $1.40 bn (from $0.98 bn) boosted by OCI gains; leverage manageable with long-term debt 6.47 bn.